Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

March 2024

Table of Contents - PeerJ (Medicine Articles)

March 29, 2024

An androgen receptor-based signature to predict prognosis and identification of ORC1 as a therapeutical target for prostate adenocarcinoma

Linjin Li, Dake Chen, Xiang Chen, Jianlong Zhu, Wenshuo Bao, Chengpeng Li, Feilong Miao, Rui Feng

https://doi.org/10.7717/peerj.16850 PubMed 38562999

March 4, 2024

Hsa_circ_0001615 downregulation inhibits esophageal cancer development through miR-142-5p/β-catenin

Yukai Dai, Qizhong Xu, Manqi Xia, Caimin Chen, Xinming Xiong, Xin Yang, Wei Wang

https://doi.org/10.7717/peerj.17089 PubMed 38464761

March 18, 2024

Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform

Xiong Shu, Hui Wen Zhang, Shi Ya Liu, Li Xin Sun, Tao Zhang, Yu Liang Ran

https://doi.org/10.7717/peerj.16817 PubMed 38515460

March 4, 2024

Identification and validation of shared gene signature of kidney renal clear cell carcinoma and COVID-19

Jianqiang Nie, Hailang Yang, Xiaoqiang Liu, Wen Deng, Bin Fu

https://doi.org/10.7717/peerj.16927 PubMed 38464749

March 15, 2024

Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma

Dong Jiang, Xia-Ling Zhu, Yan An, Yi-ran Li

https://doi.org/10.7717/peerj.16876 PubMed 38500533

March 14, 2024

Generation and characterization of mAb 61H9 against junctional adhesion molecule-a with potent antitumor activity

Kang Liu, Hang Yang, Rong Xiong, Yunlong Shen, Guiqin Song, Jinliang Yang, Zhenling Wang

https://doi.org/10.7717/peerj.17088 PubMed 38495763

← Previous
1
Next →